Scholarly Index
Yan Li
Bristol-Myers Squibb (United States); 1,709 total citations; 140 total publications; best world rank #300
Bristol-Myers Squibb (United States)
1,709Total citations
140Total publications
22H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Ubiquitin and proteasome pathways | 2021-2025 | 300 | US 77 | 90.50 |
| Protein Degradation and Inhibitors | 2021-2025 | 371 | US 173 | 92.54 |